The Spectrum of Biochemical and Haematological Alterations in COVID-19 Patients Attending a Tertiary Care Hospital in Karnataka, India
-
Published:2024-07-01
Issue:2
Volume:21
Page:723-730
-
ISSN:2456-2602
-
Container-title:Biosciences Biotechnology Research Asia
-
language:en
-
Short-container-title:Biosci., Biotech. Res. Asia
Author:
CS Nagalakshmi1ORCID, Shaikh Shaheen2ORCID, Gandham Rajeev3ORCID, N U Santhosh4ORCID
Affiliation:
1. 1Department of Biochemistry, Chikkaballapura Institute of Medical Sciences, Chikkaballapura, Karnataka, India. 2. 2Department of Biochemistry, Yenapoya Medical College, Deralakatte, Mangalore, Karnataka, India. 3. 3Department of Biochemistry, NRI Institute of Medical Sciences, Visakhapatnam, India. 4. 4Consultant Neurosurgeon (Endovascular Neurosurgeon), Aster CMI Hospital, Hebbal, Bengaluru, Karnataka, India.
Abstract
ABSTRACT: Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2), primarily acts on lungs. Most of these patients present with typical respiratory symptoms and signs. SARS-CoV-2, mainly detected by nasopharyngeal/oropharyngeal swab(s) of suspected subjects. The present study aimed at evaluating and discussing the alterations in biochemical and hematological parameters in COVID-19 patients in a tertiary care hospital. This observational study was conducted in a Tertiary care hospital, Coastal Karnataka, India. In this study, 124 COVID-19 patients were involved. Co-morbidities, such as hypertension was observed in 98 (79%), diabetes in 91 (73.3%), cardiovascular disease in 20 (16.1%), chronic kidney disease in 4 (3.2%) and liver disease in 2 (1.6%) cases. Hypertension and diabetes were more common. Symptoms such as fever was found in 109 cases (87.9%), dry cough in 102 (82.2%), fatigue in 89 (71.7%), chest tightness in 79 (63.7%), myalgia in 67 (54%) and mild shortness of breath in 46 (37%) cases. In this study, hemoglobin (9.4±1.7 %) and platelets (240.1±89.7) were decreased and erythrocyte sedimentation rate (ESR) (50.7±15.7) significantly increased in severe cases. Mean values of random blood sugar (RBS) was 245.6 ± 126.9 mg/dl, HbA1c 7.9±2.8%, serum urea 82.8±25.2 mg/dl, Creatinine 3.2±1.5 mg/dl, Uric acid 6.8±1.5 mg/dl), Total Bilirubin 1.2±0.6 mg/dl, Alkaline Phosphatase 135.4±38.9 IU/L, C-Reactive protein (CRP) 84.8±7.7 mg/L, lactate dehydrogenase (LDH) 644.6±175.1 U/L, Ferritin 828.3±195.4 µg/L, D-Dimer [2680.9 (1899.0-5475.7 ng/ml)] were elevated in severe cases than mild group. In contrast, serum total proteins (6.3±0.7g%) and globulin (2.8±0.5 g%) levels were significantly decreased in severe cases than mild/moderate cases. Study may conclude that presence of co-morbidities, abnormalities in biochemical and hematological parameters, should be regularly monitored, especially in severe / critical COVID-19 patients.
Publisher
Oriental Scientific Publishing Company
Reference32 articles.
1. 1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L, Fan G., Xu J., Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020;395(10223):497–506. 2. 2. Abhishek Agrawal., Princy Tyagi., Sunil Mahavar., Subrata Banerjee., Raman Sharma., Sudhir Bhandhari., Prakash Keswani. Study of hematological and biochemical parameters in a cohort of Indian COVID-19 patients admitted in a tertiary care centre. International Journal of Advances in Medicine, 2020;7(12):1840-1845. 3. 3. Dan Wang., Ruifang Li., Juan Wang., Qunqun Jiang., Chang Gao., Juan Yang., Lintong Ge and Qing Hu. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. BMC Infectious Diseases, 2020; 20:519:1-9. 4. 4. Liu J., Liu Y., Xiang P., Pu L., Xiong H., Li C., Zhang M., Tan J., Xu Y., Song R., Song M., Wang L., Zhang W., Han B., Yang L., Wang X.., Zhou G, Zhang T., Li B., Wang Y., Chen Z., Wang X. Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage. Journal of Translational Medicine, 2020;18(1):206. doi: 10.1186/s12967-020-02374-0. 5. 5. Iftimie S., López-Azcona AF., Vicente-Miralles M., Descarrega-Reina R., Hernández-Aguilera A., Riu F., Simó JM., Garrido P., Joven J., Camps J., Castro A. Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain. PLoS One, 2020; 15(9): e0234452. doi: 10.1371/journal.pone.0234452
|
|